Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
4
Filing Date
7/1/2026
Updated
7/2/26, 2:10 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership